{"disease":{"id":"in-utero-sars-cov-2-exposure","name":"in utero sars cov 2 exposure"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04921241","title":"In Utero Exposure to SARS-CoV-2 (COVID-19) and Cardiovascular and Metabolic Endpoints in Early Life","phase":"","overall_status":"COMPLETED","enrollment_count":86,"lead_sponsor_name":"Massachusetts General Hospital","has_results":false}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}